A Multiple Dose, Dose Escalation Trial of AEB1102 in Patients With Advanced Solid Tumors

Clinical trial NCT02561234 · COMPLETED

Trial details

NCT number: NCT02561234
Sponsor: Immedica Pharma AB
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Cancers

Start date: 2015-10-22
Primary completion: 2019-05-28
Enrollment: 76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.